ArticleInternational journal of women's health2026
Global, Regional and National Burden of Pelvic Inflammatory Disease: Trend Projections and Health Inequality Analysis, 1990-2021.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pelvic inflammatory disease (PID), a global health challenge, poses a major challenge to women's health and economic development, but has received relatively little research investment and attention. We aimed to assess the global, regional, and national burdens and trends of PID in women from 1990 to 2021. Methods: The Global Burden of Disease (GBD) 2021 standardized methodology was used to analyze the burden of PID at global, regional, and national levels, with attention to the age factor; Join-point regression was applied to identify turning points in the change in the burden of disease, and in addition, Spearman correlation analyses were used to assess the association between ASR and SDI; the study also involved a cross-countryinequality analysis with decomposition. Finally, Bayesian age-period-cohort modeling was used to predict the disease burden of pelvic inflammatory disease in 2035. Results: PID prevalence and YLDs increased over 32 years, whereas ASPR and ASYR remained relatively stable; the PID burden of disease is concentrated in the 30-39 year age group; countries with lower SDI bear a greater burden of PID, and health inequalities have declined but persist, the Inequality Slope indices of ASPR and ASYR were -22.12 (95% CI: -27.15 to -17.08) and -0.16 (95% CI: -0.20 to -0.11), respectively; population growth and aging are driving the burden of PID, with epidemiological changes driving the increase in PID but slowing the rise in YLDs; projections based on the BAPC model suggest that the burden of PID will continue to rise through 2035. Conclusion: The global burden of PID has risen and will continue to do so, with significant differences between regions and countries. Therefore, global investment in research on the epidemiology of PID should be strengthened, targeted health policies should be formulated to enhance disease management in low-income countries, female sexual health education should be strengthened, and safe and hygienic sexual lifestyles should be promoted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.